Together with ImmunityBio (NASDAQ: IBRX) from Los Angeles, she is working on an oral Covid vaccine that produced cellular immunity and antibodies in a monkey experiment. A phase 1 study is now underway in which two vaccine doses are vaccinated one after the other, in all conceivable combinations of injected and swallowed.